BIOMAT Database Logo BIOMAT Database Logo

Treatment of pulmonary and extrapulmonary tuberculosis. 2018

José Francisco Pascual-Pareja, and Raquel Carrillo-Gómez, and Victor Hontañón-Antoñana, and Mónica Martínez-Prieto
Servicio de Medicina Interna, Complejo Hospitalario La Paz- Cantoblanco-Carlos III, Madrid, España; Unidad de Tuberculosis, Complejo Hospitalario La Paz- Cantoblanco-Carlos III, Madrid, España. Electronic address: josefrancisco.pascual@salud.madrid.org.

The purpose of tuberculosis treatment is twofold: to provide an individual benefit centred on healing the patient with TB, and to provide a collective benefit to the community in which the patient resides. The different treatment regimens for tuberculosis sensitive to first-line antituberculosis drugs as well as resistant tuberculosis are examined and the peculiarities in the management of pulmonary and extrapulmonary tuberculosis are discussed.

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises
D018088 Tuberculosis, Multidrug-Resistant Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS. Tuberculosis, Drug-Resistant,Tuberculosis, MDR,Tuberculosis, Multi-Drug Resistant,Drug-Resistant Tuberculosis,MDR Tuberculosis,Multi-Drug Resistant Tuberculosis,Multidrug-Resistant Tuberculosis,Tuberculosis, Drug Resistant,Tuberculosis, Multi Drug Resistant,Tuberculosis, Multidrug Resistant

Related Publications

José Francisco Pascual-Pareja, and Raquel Carrillo-Gómez, and Victor Hontañón-Antoñana, and Mónica Martínez-Prieto
[Treatment of extrapulmonary tuberculosis and complicated forms of pulmonary tuberculosis].
September 2008, Anales de pediatria (Barcelona, Spain : 2003),
José Francisco Pascual-Pareja, and Raquel Carrillo-Gómez, and Victor Hontañón-Antoñana, and Mónica Martínez-Prieto
Pulmonary and extrapulmonary tuberculosis.
January 1998, Rays,
José Francisco Pascual-Pareja, and Raquel Carrillo-Gómez, and Victor Hontañón-Antoñana, and Mónica Martínez-Prieto
[Extrapulmonary tuberculosis in pulmonary tuberculosis].
July 1952, Revista espanola de tuberculosis,
José Francisco Pascual-Pareja, and Raquel Carrillo-Gómez, and Victor Hontañón-Antoñana, and Mónica Martínez-Prieto
Streptomycin in the treatment of pulmonary and extrapulmonary tuberculosis.
February 1949, La Semana medica,
José Francisco Pascual-Pareja, and Raquel Carrillo-Gómez, and Victor Hontañón-Antoñana, and Mónica Martínez-Prieto
[Local treatment of pulmonary and extrapulmonary tuberculosis with ethambutol].
April 1970, La Clinica terapeutica,
José Francisco Pascual-Pareja, and Raquel Carrillo-Gómez, and Victor Hontañón-Antoñana, and Mónica Martínez-Prieto
Antibiotic and chemotherapy treatment in pulmonary and extrapulmonary tuberculosis.
September 1949, Accademia medica,
José Francisco Pascual-Pareja, and Raquel Carrillo-Gómez, and Victor Hontañón-Antoñana, and Mónica Martínez-Prieto
[Pulmonary tuberculosis and extrapulmonary carcinoma].
June 1960, Wiener medizinische Wochenschrift (1946),
José Francisco Pascual-Pareja, and Raquel Carrillo-Gómez, and Victor Hontañón-Antoñana, and Mónica Martínez-Prieto
[Treatment of extrapulmonary & pulmonary tuberculosis with tuberculostatics & prednisone-ACTH].
August 1958, La Semana medica,
José Francisco Pascual-Pareja, and Raquel Carrillo-Gómez, and Victor Hontañón-Antoñana, and Mónica Martínez-Prieto
[Relations between pulmonary and extrapulmonary tuberculosis].
January 1950, Atti della Accademia dei fisiocritici in Siena. Sezione medico-fisica,
José Francisco Pascual-Pareja, and Raquel Carrillo-Gómez, and Victor Hontañón-Antoñana, and Mónica Martínez-Prieto
[Pyruvicemia in pulmonary and extrapulmonary tuberculosis].
January 1967, Annali dell'Istituto "Carlo Forlanini",
Copied contents to your clipboard!